Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

June 27, 2018

Study Completion Date

July 30, 2018

Conditions
Anorexia NervosaOsteoporosis
Interventions
DRUG

estradiol 0.045 mg/levonorgestrel 0.015mg

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Massachusetts General Hospital

OTHER

NCT02475265 - Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa | Biotech Hunter | Biotech Hunter